Here are six insights:
1. Zacks has a $0.25 target price on the stock.
2. Zacks’ price objective sees an upside of 78.57 percent from the stock’s current price.
3. Cytori shares opened at 0.14 on Feb. 9.
4. The market cap is $22.19 million.
5. The company has a 52-week low of $0.14 and a 52-week high of $1.47.
6. The 50-day moving average is $0.18 and the 200-day moving average is $0.32.
More articles on devices:
FDA schedules meeting to review Cartiva’s PMA for synthetic cartilage implant: 4 points
Zimmer Biomet investors to offer 11M+ shares of common stock: 5 takeaways
Smith & Nephew insider sells 11k+ shares: 4 facts
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
